Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries-Reference-Cited by-同舟云学术

Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries

Published:2016-08 Issue:6 Volume:12 Page:734-739
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Oemrawsingh Rohit M.,Garcia-Garcia Hector M.,van Geuns Robert J.M.,Lenzen Mattie J.,Simsek Cihan,de Boer Sanneke P.M.,Van Mieghem Nicolas M.,Regar Evelyn,de Jaegere Peter P.T.,Akkerhuis K. Martijn,Ligthart Jurgen M.R.,Zijlstra Felix,Serruys Patrick W.,Boersma Eric

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Hybrid Intracoronary Imaging Technologies and Their Applications in Clinical Practice and Research;JACC: Cardiovascular Interventions;2024-09

2. Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression;American Journal of Preventive Cardiology;2024-06

3. Impact of lipid lowering on coronary atherosclerosis moving from the lumen to the artery wall;Atherosclerosis;2023-02

4. Wall shear stress–related plaque growth of lipid-rich plaques in human coronary arteries: an near-infrared spectroscopy and optical coherence tomography study;Cardiovascular Research;2022-12-28

5. Prognostic value of syntax score, intravascular ultrasound and near-infrared spectroscopy to identify low-risk patients with coronary artery disease 5-year results from the ATHEROREMO and IBIS-3 cohorts;PLOS ONE;2022-11-10